Novo Holdings A/S’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,987,506
| Closed | -$4.99M | – | 46 |
|
|
2020
Q3 | $4.99M | Hold |
1,987,506
| – | – | 0.25% | 40 |
|
|
2020
Q2 | $27M | Sell |
1,987,506
-1,405,533
| -41% | -$19.1M | 1.74% | 12 |
|
|
2020
Q1 | $25.7M | Buy |
3,393,039
+293,039
| +9% | +$2.22M | 1.72% | 9 |
|
|
2019
Q4 | $19.6M | Hold |
3,100,000
| – | – | 1.26% | 11 |
|
|
2019
Q3 | $12.2M | Hold |
3,100,000
| – | – | 2.08% | 13 |
|
|
2019
Q2 | $15M | Hold |
3,100,000
| – | – | 2.1% | 12 |
|
|
2019
Q1 | $25.4M | Hold |
3,100,000
| – | – | 3.76% | 6 |
|
|
2018
Q4 | $17.1M | Hold |
3,100,000
| – | – | 2.41% | 8 |
|
|
2018
Q3 | $27.4M | Hold |
3,100,000
| – | – | 2.17% | 5 |
|
|
2018
Q2 | $30.9M | Hold |
3,100,000
| – | – | 3.11% | 5 |
|
|
2018
Q1 | $29.5M | Buy |
3,100,000
+875,000
| +39% | +$8.34M | 3.7% | 6 |
|
|
2017
Q4 | $33.1M | Buy |
2,225,000
+337,465
| +18% | +$5.02M | 4.64% | 5 |
|
|
2017
Q3 | $37.1M | Buy |
1,887,535
+73,246
| +4% | +$1.44M | 4.83% | 6 |
|
|
2017
Q2 | $26.1M | Buy |
1,814,289
+542,042
| +43% | +$7.79M | 3.12% | 9 |
|
|
2017
Q1 | $11.7M | Buy |
+1,272,247
| New | +$11.7M | 1.25% | 16 |
|
|
2015
Q4 | – | Sell |
-1,516,387
| Closed | -$14.6M | – | 16 |
|
|
2015
Q3 | $14.6M | Hold |
1,516,387
| – | – | 1.51% | 11 |
|
|
2015
Q2 | $15.6M | Hold |
1,516,387
| – | – | 1.12% | 14 |
|
|
2015
Q1 | $16.8M | Hold |
1,516,387
| – | – | 1.43% | 10 |
|
|
2014
Q4 | $17.7M | Hold |
1,516,387
| – | – | 1.43% | 11 |
|
|
2014
Q3 | $33.6M | Hold |
1,516,387
| – | – | 3.27% | 7 |
|
|
2014
Q2 | $42.1M | Buy |
+1,516,387
| New | +$42.1M | 4.17% | 6 |
|